1. Contrasting pathogen prevalence between tick and dog populations at Chornobyl.
- Author
-
Dillon MN, Qurollo BA, Thomas R, Warren ME, Mousseau TA, Betz JA, Kleiman NJ, and Breen M
- Subjects
- Animals, Dogs, Prevalence, Tick-Borne Diseases epidemiology, Tick-Borne Diseases veterinary, Tick-Borne Diseases parasitology, Tick-Borne Diseases microbiology, Ukraine epidemiology, Babesia isolation & purification, Female, Tick Infestations veterinary, Tick Infestations epidemiology, Tick Infestations parasitology, Ticks microbiology, Ticks parasitology, Male, Dog Diseases epidemiology, Dog Diseases parasitology, Dog Diseases microbiology, Chernobyl Nuclear Accident
- Abstract
Background: The 1986 disaster at the Chornobyl Nuclear Power Plant released massive amounts of radioactive material into the local environment. In addition to radiation, remediation efforts and abandonment of military-industrial complexes contributed to contamination with heavy metals, organics, pesticides and other toxic chemicals. Numerous studies have evaluated the effects of this contamination on the local ecology. However, few studies have reported the effect of this contamination on vector-borne pathogens and their hosts. In this manuscript, we characterize tick-borne pathogen presence at two sample locations within the Chornobyl Exclusion Zone, one at the Nuclear Power Plant (NPP) and another 16 km away in Chornobyl City (CC)., Methods: Ticks and whole-blood samples were collected from free-breeding dogs captured at the NPP and CC. Endpoint PCR and quantitative PCR were used to identify tick species and to assess the presence of specific tick-borne pathogens, including Anaplasma phagocytophilum, Borrelia burgdorferi sensu lato, Babesia spp., Bartonella spp., Francisella tularensis and general Anaplasmataceae. A droplet digital PCR assay was developed for Babesia canis and A. phagocytophilum to evaluate their presence in dogs from the two populations. Pathogen prevalences between the two sample populations were compared by calculating Z-scores., Results: Ticks were identified as Ixodes ricinus (n = 102) and Dermacentor reticulatus (n = 4). Overall, 56.9% of I. ricinus ticks were positive for at least one pathogen. A significantly higher prevalence of A. phagocytophilum and B. burgdorferi was found in ticks at the NPP (44.0% and 42.0%, respectively) compared to CC (23.1% and 19.2%, respectively). Babesia spp. (including B. canis and B. caballi) were detected in 8.8% ticks at similar proportions for both populations. Interestingly, we found a significantly lower level of A. phagocytophilum in dogs at the NPP (1.8%) than in dogs at CC (11.7%). In total, 24.3% of dogs were positive for B. canis, evenly distributed across the two populations., Conclusions: The results of this study show contrasting pathogen prevalence in both ticks and dogs at the NPP and CC, which may reflect the differential exposures at the two locations. This work adds an important new component to our understanding of the consequences of prolonged exposure to environmental contamination on the wildlife and ecology within the Chornobyl Exclusion Zone., Competing Interests: Declarations Ethics approval and consent to participate The Chornobyl Nuclear Power Plant authorities under the supervision of licensed veterinarians and veterinary technicians conducted the ethical review and provided permission for the animal study. A letter of support detailing the cooperation between the Clean Futures Fund and the Chornobyl NPP was signed by the NPP acting general director V.A. Seyda and can be provided by TAM upon request. Approval for access to the exclusion zone was handled and granted by the Exclusion Zone Authority. Samples collected for this study were gathered adventitiously while animals were being treated by the medical program and as such are exempt from IACUC approval. Consent for publication Not applicable. Competing interests BAQ receives partial salary support from IDEXX Laboratories, Inc and has been a paid consultant during the development and validation of rapid assays developed by IDEXX Laboratories for veterinary medical applications. The other authors have no competing interests to declare., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF